Literature DB >> 16059744

Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia.

Hana Shimizu1, Moedrik Tamam2,3, Augustinus Soemantri2,3, Takafumi Ishida4.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency and Southeast Asian ovalocytosis (SAO) caused by a 27-bp deletion in the band 3 gene (Band3Delta 27) are well-documented genetic traits resistant to malarial diseases; however, relationships between these traits and asymptomatic malaria infection hitherto had not been investigated. Filter-blotted blood samples were collected from a total of 210 healthy individuals, 100 males and 110 females, aged 6-17 years, in Sumba island, Indonesia, to survey for the presence of Plasmodium parasites, G6PD activity and the Band3Delta 27 mutation. Presence of P. falciparum and/or P. vivax was identified in 25 subjects (11.9%). In all, 24 subjects (11.4%) showed Band3Delta 27 heterozygously. In males and females, eight and nine subjects, respectively, showed G6PD deficiency. There was no significant difference in the prevalence of asymptomatic malaria infection between individuals with or without these traits (P>0.05). No alterations in the prevalence of asymptomatic malaria infection suggest that parasite invasion into erythrocytes is unlikely to be a target phase in which the two polymorphisms demonstrate possible protective effects against malaria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16059744     DOI: 10.1007/s10038-005-0271-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Distribution of a 27-bp deletion in the band 3 gene in South Pacific islanders.

Authors:  Masako Kimura; Moedrik Tamam; Augustinus Soemantri; Minato Nakazawa; Yuji Ataka; Ryutaro Ohtsuka; Takafumi Ishida
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

2.  Twenty-seven base pair deletion in erythrocyte band 3 protein gene responsible for Southeast Asian ovalocytosis is not common among Southeast Asians.

Authors:  M Kimura; Y Shimizu; W Settheetham-Ishida; A Soemantri; D Tiwawech; A Romphruk; P Duangchan; T Ishida
Journal:  Hum Biol       Date:  1998-12       Impact factor: 0.553

Review 3.  Host-parasite interaction and morbidity in malaria endemic areas.

Authors:  K Marsh; R W Snow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  The adaptation of Plasmodium falciparum to oxidative stress in G6PD deficient human erythrocytes.

Authors:  E Roth; S Schulman
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

5.  Ovalocytosis and cerebral malaria.

Authors:  B Genton; F al-Yaman; C S Mgone; N Alexander; M M Paniu; M P Alpers; D Mokela
Journal:  Nature       Date:  1995-12-07       Impact factor: 49.962

6.  Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria.

Authors:  N Mohandas; L E Lie-Injo; M Friedman; J W Mak
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren.

Authors:  Landry-Erik Mombo; Francine Ntoumi; Cyrille Bisseye; Simon Ossari; Chang Yong Lu; Ronald L Nagel; Rajagopal Krishnamoorthy
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

8.  Five different glucose-6-phophate [correction phosphate]dehydrogenase (G6PD) variants found among 11 G6PD-deficient persons in Flores Island, Indonesia.

Authors:  Hiroyuki Matsuoka; Meiji Arai; Shigeto Yoshida; Indah Setyawati Tantular; Suhintam Pusarawati; Henyo Kerong; Fumihiko Kawamoto
Journal:  J Hum Genet       Date:  2003-09-23       Impact factor: 3.172

9.  Nucleotide variability at G6pd and the signature of malarial selection in humans.

Authors:  Matthew A Saunders; Michael F Hammer; Michael W Nachman
Journal:  Genetics       Date:  2002-12       Impact factor: 4.562

10.  Ovalocytic erythrocytes from Melanesians are resistant to invasion by malaria parasites in culture.

Authors:  C Kidson; G Lamont; A Saul; G T Nurse
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  11 in total

1.  The Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran.

Authors:  Mohammad Ebrahimipour; Mehdi Nateghpour; Homa Hajjaran; Gholamhosein Edrissian; Mahmood Jalali; Ahmad Raeisi; Afsaneh Motevalli Haghi; Leila Farivar; Masomeh Khodadadi; Abas Rahimi-Froushani
Journal:  Iran J Parasitol       Date:  2014-09       Impact factor: 1.012

Review 2.  Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.

Authors:  Lorenz von Seidlein; Sarah Auburn; Fe Espino; Dennis Shanks; Qin Cheng; James McCarthy; Kevin Baird; Catherine Moyes; Rosalind Howes; Didier Ménard; Germana Bancone; Ari Winasti-Satyahraha; Lasse S Vestergaard; Justin Green; Gonzalo Domingo; Shunmay Yeung; Ric Price
Journal:  Malar J       Date:  2013-03-27       Impact factor: 2.979

3.  Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study.

Authors:  Anna Rosanas-Urgell; Enmoore Lin; Laurens Manning; Patricia Rarau; Moses Laman; Nicolas Senn; Brian T Grimberg; Livingstone Tavul; Danielle I Stanisic; Leanne J Robinson; John J Aponte; Elijah Dabod; John C Reeder; Peter Siba; Peter A Zimmerman; Timothy M E Davis; Christopher L King; Pascal Michon; Ivo Mueller
Journal:  PLoS Med       Date:  2012-09-04       Impact factor: 11.069

4.  Plasmodium vivax malaria endemicity in Indonesia in 2010.

Authors:  Iqbal R F Elyazar; Peter W Gething; Anand P Patil; Hanifah Rogayah; Elvieda Sariwati; Niken W Palupi; Siti N Tarmizi; Rita Kusriastuti; J Kevin Baird; Simon I Hay
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

Review 5.  Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Authors:  Bridget S Penman; Sunetra Gupta; David J Weatherall
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

6.  Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.

Authors:  Nicholas M Douglas; Daniel A Lampah; Enny Kenangalem; Julie A Simpson; Jeanne R Poespoprodjo; Paulus Sugiarto; Nicholas M Anstey; Ric N Price
Journal:  PLoS Med       Date:  2013-12-17       Impact factor: 11.069

7.  G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.

Authors:  Ari Winasti Satyagraha; Arkasha Sadhewa; Vanessa Baramuli; Rosalie Elvira; Chase Ridenour; Iqbal Elyazar; Rintis Noviyanti; Farah Novita Coutrier; Alida Roswita Harahap; J Kevin Baird
Journal:  PLoS Negl Trop Dis       Date:  2015-03-06

8.  Solenostemon monostachyus, Ipomoea involucrata and Carica papaya seed oil versus Glutathione, or Vernonia amygdalina: methanolic extracts of novel plants for the management of sickle cell anemia disease.

Authors:  Israel Sunmola Afolabi; Iyanuoluwa Olubukola Osikoya; Oluwabukunmi Dorcas Fajimi; Priscilla Ibanga Usoro; Damilola Olufunlayo Ogunleye; Tolulope Bisi-Adeniyi; Alaba O Adeyemi; Bosede Temitope Adekeye
Journal:  BMC Complement Altern Med       Date:  2012-12-22       Impact factor: 3.659

9.  Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea.

Authors:  Freya J I Fowkes; Pascal Michon; Lynn Pilling; Ruth M Ripley; Livingstone Tavul; Heather J Imrie; Caira M Woods; Charles S Mgone; Adrian J F Luty; Karen P Day
Journal:  Malar J       Date:  2008-01-03       Impact factor: 2.979

Review 10.  Immunoregulation in human malaria: the challenge of understanding asymptomatic infection.

Authors:  Vitor R de Mendonça; Manoel Barral-Netto
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.